Studies have shown that LDL receptors are overexpressed in some malignant tumor cells(Hu et al., 2011), especially in acute myeloidleukemia, rectal cancer, adrenal cancer, liver cancer, brain cancer, metastatic prostatecancer cells, and most importantly for here, lung cancer. This evidence concerns the gene LDLR and lung cancer.